{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:42:30Z","timestamp":1793371350501,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clinbiochem.2024.110854","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T17:57:26Z","timestamp":1731866246000},"page":"110854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Evaluation of the applicability of urine lateral flow immunochromatography tests for the detection of cocaine in plasma samples"],"prefix":"10.1016","volume":"135","author":[{"given":"Isabella Almeida Millan","family":"de Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Pereira","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Nunes","family":"do Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia","family":"Birk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane Cristina","family":"Sebben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Eller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago Franco","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2024.110854_b0005","unstructured":"UNODC, Global Report on Cocaine 2023 \u2013 Local dynamics, global challenges, United Nations publications, Vienna, 2023. https:\/\/www.unodc.org\/documents\/data-and-analysis\/cocaine\/Global_cocaine_report_2023.pdf."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0010","unstructured":"F.I.P. Bastos, M.T.L. de Vasconcellos, R.B. De Boni, N.B. dos Reis, C.F. de S. Coutinho, III Levantamento Nacional sobre o uso de drogas pela popula\u00e7\u00e3o brasileira, (2017) 528. https:\/\/www.arca.fiocruz.br\/handle\/icict\/34614."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0015","unstructured":"CIT\/RS, Relat\u00f3rio Anual 2022, Centro de Informa\u00e7\u00e3o Toxicol\u00f3gica do Rio Grande do Sul, Porto Alegre, 2023. http:\/\/www.cit.rs.gov.br\/index.php?option=com_content&view=article&id=137&Itemid."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0020","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1161\/CIRCULATIONAHA.110.940569","article-title":"Cardiovascular effects of cocaine","volume":"122","author":"Schwartz","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2024.110854_b0025","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ccc.2012.07.003","article-title":"Cocaine intoxication","volume":"28","author":"Zimmerman","year":"2012","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacc.2017.05.014","article-title":"The cardiovascular effects of cocaine","volume":"70","author":"Havakuk","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0035","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-020-00762-9","article-title":"Management of pharmaceutical and recreational drug poisoning","volume":"10","author":"M\u00e9garbane","year":"2020","journal-title":"Ann. Intensive Care."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0040","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.mayocp.2016.12.007","article-title":"Clinical interpretation of urine drug tests: what clinicians need to know about urine drug screens","volume":"92","author":"Moeller","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0045","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1177\/0897190015579611","article-title":"What can a urine drug screening immunoassay really tell us?","volume":"29","author":"Nelson","year":"2016","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0009-8981(01)00714-8","article-title":"Urine drug screening in the medical setting","volume":"315","author":"Hammett-Stabler","year":"2002","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2019.106649","article-title":"Comparison of several immunoassays used in drugs of abuse screening: Assessment against gold standard methods and calculation of measurement uncertainty","volume":"101","author":"Mina","year":"2020","journal-title":"J. Pharmacol. Toxicol. Methods."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0060","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/00365513.2014.939995","article-title":"Laboratory and clinical evaluation of on-site urine drug testing","volume":"74","author":"Beck","year":"2014","journal-title":"Scand. J. Clin Lab. Invest."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0065","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/dta.2178","article-title":"European guidelines for workplace drug testing in urine","volume":"9","author":"Taskinen","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0070","article-title":"A validated dilute-and-shoot LC-MS\/MS urine screening for the analysis of 95 illicit drugs and medicines: insights from clinical and forensic Brazilian cases","author":"Pereira dos Santos","year":"2024","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.toxrep.2017.12.001","article-title":"Clinical value of drugs of abuse point of care testing in an emergency department setting","volume":"5","author":"Lager","year":"2018","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0080","unstructured":"SAMHSA, Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine, (2023) 70768\u201370811. https:\/\/www.federalregister.gov\/documents\/2023\/10\/12\/2023-21734\/mandatory-guidelines-for-federal-workplace-drug-testing-programs."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0085","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00007691-200404000-00020","article-title":"Detection times of drugs of abuse in blood, urine, and oral fluid","volume":"26","author":"Verstraete","year":"2004","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0090","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1258\/acb.2011.011116","article-title":"Screening for drugs of abuse: which matrix, oral fluid or urine?","volume":"48","author":"Allen","year":"2011","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jat\/bkx085","article-title":"Comparison of cocaine\/crack biomarkers concentrations in oral fluid, urine and plasma simultaneously collected from drug users","volume":"42","author":"Fiorentin","year":"2018","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0100","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ajem.2021.08.057","article-title":"Relationship between cocaine and cocaethylene blood concentration with the severity of clinical manifestations","volume":"50","author":"Zucoloto","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0105","unstructured":"D. Uges, Hospital Toxicology, in: A.C. Moffat, M.D. Osselton, B. Widdop (Eds.), Clarke\u2019s Anal. Drugs Poisons, 4th ed., Pharmaceutical Press, London, 2011: pp. 3\u201358."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115082","article-title":"A multi-analyte LC-MS\/MS method for the determination of 57 pharmaceuticals and illicit drugs in plasma, and its application to poisoning cases","volume":"222","author":"dos Santos","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s13181-022-00916-0","article-title":"Biostatistics and epidemiology principles for the toxicologist: the \u201ctesty\u201d test characteristics part I\u2014sensitivity and specificity","volume":"19","author":"Sahag\u00fan","year":"2023","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0120","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s13181-023-00953-3","article-title":"Biostatistics and epidemiology principles for the toxicologist: the \u201ctesty\u201d test characteristics part II: positive predictive value and negative predictive value","volume":"19","author":"Williams","year":"2023","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jat\/34.2.57","article-title":"Urinary excretion of ecgonine and five other cocaine metabolites following controlled oral, intravenous, intranasal, and smoked administration of cocaine","volume":"34","author":"Smith","year":"2010","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/toxins14040278","article-title":"Cocaine: an updated overview on chemistry, detection, biokinetics, and pharmacotoxicological aspects including abuse pattern","volume":"14","author":"Roque Bravo","year":"2022","journal-title":"Toxins (basel)"},{"key":"10.1016\/j.clinbiochem.2024.110854_b0135","first-page":"49","article-title":"Simultaneous determination of cocaine and metabolites in human plasma using solid phase micro-extraction fiber tips C18 and UPLC-MS\/MS","volume":"44","author":"Lizot","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0140","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/jat\/bkaa044","article-title":"Stability of cocaine compounds in biological fluids during post-analytical sample storage","volume":"44","author":"Huertas","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/jat\/25.3.174","article-title":"Positive predictive values of abused drug immunoassays on the beckman synchron in a veteran population","volume":"25","author":"Dietzen","year":"2001","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0150","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.drugalcdep.2016.04.004","article-title":"Pharmacodynamic effects and relationships to plasma and oral fluid pharmacokinetics after intravenous cocaine administration","volume":"163","author":"Ellefsen","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0155","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jat\/bky007","article-title":"Bioavailability and pharmacokinetics of oral cocaine in humans","volume":"42","author":"Coe","year":"2018","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0009-8981(99)00249-1","article-title":"Detection of cocaine metabolite in serum and urine: frequency and correlation with medical diagnosis","volume":"295","author":"Linder","year":"2000","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jat\/27.4.205","article-title":"Evaluation of immunochemical drug screenings of whole blood samples. A retrospective optimization of cutoff levels after confirmation-analysis on GC-MS and HPLC-DAD","volume":"27","author":"Kroener","year":"2003","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0170","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.forsciint.2011.06.029","article-title":"Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum on Hitachi 912","volume":"212","author":"Kirschbaum","year":"2011","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.forc.2017.12.007","article-title":"LC\u2013MS\/MS screening strategy for cannabinoids, opiates, amphetamines, cocaine, benzodiazepines and methadone in human serum, urine and post-mortem blood as an effective alternative to immunoassay based methods applied in forensic toxicology for preliminary","volume":"7","author":"Dziadosz","year":"2018","journal-title":"Forensic Chem."},{"key":"10.1016\/j.clinbiochem.2024.110854_b0180","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1373\/clinchem.2019.305409","article-title":"Discovering cross-reactivity in urine drug screening immunoassays through large-scale analysis of electronic health records","volume":"65","author":"Hughey","year":"2019","journal-title":"Clin. Chem."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024001486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024001486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T09:51:15Z","timestamp":1736848275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912024001486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":36,"alternative-id":["S0009912024001486"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110854","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the applicability of urine lateral flow immunochromatography tests for the detection of cocaine in plasma samples","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110854"}}